Free Trial
→ Here’s Why Trump Won’t End The Iran War (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Crexendo Inc. stock logo
CXDO
Crexendo
$5.92
+0.6%		$6.14
$5.54
▼
$11.23
$196.53M1.15363,893 shs87,835 shs
Kaltura, Inc. stock logo
KLTR
Kaltura
$1.37
+3.4%		$1.48
$1.06
▼
$2.05
$208.23M1.2522,920 shs184,641 shs
Marchex, Inc. stock logo
MCHX
Marchex
$1.30
+1.2%		$1.58
$1.15
▼
$2.03
$57.42M1.924,216 shs18,679 shs
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
$5.32
-6.0%		$3.68
$2.11
▼
$21.41
$281.96M-0.29295,606 shs241,749 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Crexendo Inc. stock logo
CXDO
Crexendo
0.00%-0.68%+2.80%-28.38%-0.34%
Kaltura, Inc. stock logo
KLTR
Kaltura
0.00%+0.76%-6.38%+2.33%-11.41%
Marchex, Inc. stock logo
MCHX
Marchex
0.00%-0.78%-6.23%-24.71%-34.69%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
0.00%+42.57%+84.36%-21.39%-63.95%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Crexendo Inc. stock logo
CXDO
Crexendo
$5.92
+0.6%		$6.14
$5.54
▼
$11.23
$196.53M1.15363,893 shs87,835 shs
Kaltura, Inc. stock logo
KLTR
Kaltura
$1.37
+3.4%		$1.48
$1.06
▼
$2.05
$208.23M1.2522,920 shs184,641 shs
Marchex, Inc. stock logo
MCHX
Marchex
$1.30
+1.2%		$1.58
$1.15
▼
$2.03
$57.42M1.924,216 shs18,679 shs
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
$5.32
-6.0%		$3.68
$2.11
▼
$21.41
$281.96M-0.29295,606 shs241,749 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Crexendo Inc. stock logo
CXDO
Crexendo
0.00%-0.68%+2.80%-28.38%-0.34%
Kaltura, Inc. stock logo
KLTR
Kaltura
0.00%+0.76%-6.38%+2.33%-11.41%
Marchex, Inc. stock logo
MCHX
Marchex
0.00%-0.78%-6.23%-24.71%-34.69%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
0.00%+42.57%+84.36%-21.39%-63.95%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Crexendo Inc. stock logo
CXDO
Crexendo
2.75
Moderate Buy$10.5077.51% Upside
Kaltura, Inc. stock logo
KLTR
Kaltura
2.00
Hold$3.00119.78% Upside
Marchex, Inc. stock logo
MCHX
Marchex
1.50
ReduceN/AN/A
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest MCHX, ZSQR, KLTR, and CXDO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/11/2026
Kaltura, Inc. stock logo
KLTR
Kaltura
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
8/14/2026
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E-)
8/5/2026
Crexendo Inc. stock logo
CXDO
Crexendo
B. Riley Financial, Inc. logo
B. Riley Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$10.00 ➝ $9.00
8/3/2026
Crexendo Inc. stock logo
CXDO
Crexendo
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C+)
7/17/2026
Marchex, Inc. stock logo
MCHX
Marchex
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
(Data available from 10/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Crexendo Inc. stock logo
CXDO
Crexendo
$80.91M2.43$0.38 per share15.72$2.08 per share2.84
Kaltura, Inc. stock logo
KLTR
Kaltura
$180.85M1.15$0.07 per share19.23$0.04 per share34.13
Marchex, Inc. stock logo
MCHX
Marchex
$45.42M1.26N/AN/A$0.69 per share1.88
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
$1.36M207.32N/AN/A$2.63 per share2.02
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Crexendo Inc. stock logo
CXDO
Crexendo
$5.07M$0.1442.2115.99N/A5.31%14.34%11.44%11/3/2026 (Estimated)
Kaltura, Inc. stock logo
KLTR
Kaltura
-$12.07M-$0.09N/AN/AN/A-6.92%-51.05%-2.33%11/9/2026 (Estimated)
Marchex, Inc. stock logo
MCHX
Marchex
-$5.24M-$0.12N/A10.79N/A-12.44%-18.25%-13.94%11/12/2026 (Estimated)
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
-$11.92M-$1.63N/AN/AN/A-773.72%-49.45%-46.88%N/A

Latest MCHX, ZSQR, KLTR, and CXDO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/9/2026Q3 2026
Kaltura, Inc. stock logo
KLTR
Kaltura
-$0.01N/AN/AN/A$46.15 millionN/A
11/3/2026Q3 2026
Crexendo Inc. stock logo
CXDO
Crexendo
$0.11N/AN/AN/A$25.18 millionN/A
8/13/2026Q2 2026
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/A-$0.28N/A-$0.28N/A$1.58 million
8/12/2026Q2 2026
Marchex, Inc. stock logo
MCHX
Marchex
$0.02-$0.01-$0.03-$0.01$11.20 million$11.00 million
8/5/2026Q2 2026
Kaltura, Inc. stock logo
KLTR
Kaltura
-$0.0088$0.01+$0.0188-$0.04$45.60 million$46.89 million
8/4/2026Q2 2026
Crexendo Inc. stock logo
CXDO
Crexendo
$0.0967$0.12+$0.0233$0.03$24.65 million$24.65 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Crexendo Inc. stock logo
CXDO
Crexendo
N/AN/AN/AN/AN/A
Kaltura, Inc. stock logo
KLTR
Kaltura
N/AN/AN/AN/AN/A
Marchex, Inc. stock logo
MCHX
Marchex
N/AN/AN/AN/AN/A
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Crexendo Inc. stock logo
CXDO
Crexendo
0.06
2.06
1.98
Kaltura, Inc. stock logo
KLTR
Kaltura
N/A
0.56
0.56
Marchex, Inc. stock logo
MCHX
Marchex
N/A
2.29
2.29
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/A
7.66
7.66

Institutional Ownership

CompanyInstitutional Ownership
Crexendo Inc. stock logo
CXDO
Crexendo
9.53%
Kaltura, Inc. stock logo
KLTR
Kaltura
30.79%
Marchex, Inc. stock logo
MCHX
Marchex
73.46%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
13.88%

Insider Ownership

CompanyInsider Ownership
Crexendo Inc. stock logo
CXDO
Crexendo
47.20%
Kaltura, Inc. stock logo
KLTR
Kaltura
16.30%
Marchex, Inc. stock logo
MCHX
Marchex
23.49%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
24.25%
CompanyEmployeesShares OutstandingFree FloatOptionable
Crexendo Inc. stock logo
CXDO
Crexendo
19333.25 million17.62 millionOptionable
Kaltura, Inc. stock logo
KLTR
Kaltura
494152.55 million127.69 millionOptionable
Marchex, Inc. stock logo
MCHX
Marchex
13944.34 million33.92 millionOptionable
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
653.00 million40.15 millionNot Optionable

Recent News About These Companies

Z Squared Inc. CEO David Halabu Discusses AI Data Center Strategy on Two Investor Podcasts
September 18, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-inc-ceo-david-halabu-discusses-ai-data-center-strategy-on-two-investor-podcasts-302882806.html
Z Squared Acquires Energized Arkansas Campus to Advance AI Infrastructure Strategy
September 9, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-acquires-energized-arkansas-campus-to-advance-ai-infrastructure-strategy-302873400.html
Z Squared CEO to Shareholders: "The Scarcest Thing in AI is Not Chips. It is Power.
August 14, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-ceo-to-shareholders-the-scarcest-thing-in-ai-is-not-chips-it-is-power-302851841.html
Z Squared Inc. Signs Definitive Agreement to Acquire 100% of Paradox Data and Its Union County Campus
August 3, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-inc-signs-definitive-agreement-to-acquire-100-of-paradox-data-and-its-union-county-campus-302840797.html
Z Squared Inc. Terminates At-The-Market Sales Agreement and Committed Equity Forward Purchase Agreement
July 17, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-inc-terminates-at-the-market-sales-agreement-and-committed-equity-forward-purchase-agreement-302828055.html
Z Squared Inc. Provides Capital Structure Update
July 15, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-inc-provides-capital-structure-update-302826454.html
Z Squared Inc. Appoints Jeffrey Harris as Chief Technology Officer
June 30, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-inc-appoints-jeffrey-harris-as-chief-technology-officer-302814078.html
Z Squared Raises Approximately $15.3 Million in Non-Debt Capital to Advance AI Infrastructure Strategy
June 29, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-raises-approximately-15-3-million-in-non-debt-capital-to-advance-ai-infrastructure-strategy-302813716.html
Russell Indexes Add Z Squared Inc. to Russell 2000® and Russell 3000®
June 29, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/russell-indexes-add-z-squared-inc-to-russell-2000-and-russell-3000-302812718.html
Z Squared, Inc. to Acquire Majority Interest in Paradox Data and Its Union County Campus, a Next-Generation Data Center Development Targeting Up to 150 MW of Firm Power
June 25, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-inc-to-acquire-majority-interest-in-paradox-data-and-its-union-county-campus-a-next-generation-data-center-development-targeting-up-to-150-mw-of-firm-power-302810183.html
Z Squared to Participate in Maxim Group's AI Data Center Summit
June 9, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-to-participate-in-maxim-groups-ai-data-center-summit-302794415.html
Z Squared, Inc. Enters $50 Million Committed Equity Forward Purchase Agreement to Support AI Infrastructure Buildout
June 4, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-inc-enters-50-million-committed-equity-forward-purchase-agreement-to-support-ai-infrastructure-buildout-302791528.html
Z Squared, Inc. Announces Preliminary Inclusion in Russell 3000® and Russell 2000® Indexes
May 27, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-inc-announces-preliminary-inclusion-in-russell-3000-and-russell-2000-indexes-302782976.html
Vanderbilt Report: Z Squared Locks In Zero-Cash, Zero-Debt Path to 42 MW of AI-Ready Power
May 26, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/26/3301053/0/en/vanderbilt-report-z-squared-locks-in-zero-cash-zero-debt-path-to-42-mw-of-ai-ready-power.html
Z Squared, Inc. Outlines Phase 1 Plan to Reach 100 MW of AI-Ready Infrastructure for Inference Workloads
May 19, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-inc-outlines-phase-1-plan-to-reach-100-mw-of-ai-ready-infrastructure-for-inference-workloads-302775928.html
Z Squared Appoints Jon Najarian, Pete Najarian, Marc LoPresti and Jay Zapata to Newly Formed Advisory Board
May 4, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-appoints-jon-najarian-pete-najarian-marc-lopresti-and-jay-zapata-to-newly-formed-advisory-board-302761728.html
Z Squared to Acquire Skycore Digital, Adding 24 MW of Energized AI Infrastructure with Expansion Path to 42 MW
April 29, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-to-acquire-skycore-digital-adding-24-mw-of-energized-ai-infrastructure-with-expansion-path-to-42-mw-302756527.html
Z Squared, Inc. to Ring the Nasdaq Closing Bell in Celebration of Its Listing on the Nasdaq Global Market
April 28, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-inc-to-ring-the-nasdaq-closing-bell-in-celebration-of-its-listing-on-the-nasdaq-global-market-302756362.html
Coeptis Therapeutics Announces Approval of Z Squared Inc.'s Nasdaq Listing Application
April 27, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-04/68143246-coeptis-therapeutics-announces-approval-of-z-squared-inc-s-nasdaq-listing-application-399.htm
Z Squared Provides Additional Information on Previously Disclosed Pro Rata Distribution
April 27, 2026  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2026/04/27/10371853.htm

New MarketBeat Followers Over Time

Media Sentiment Over Time

Crexendo stock logo

Crexendo NASDAQ:CXDO

$5.92 +0.04 (+0.60%)
As of 02:16 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Crexendo, Inc. provides cloud communication platform and services, video collaboration, and managed IT services for businesses in the United States and internationally. It operates through two segments, Cloud Telecommunications Services and Software Solutions. The Cloud Telecommunications segment provides telecommunications services that transmit calls using Internet protocol (IP) or cloud technology, which converts voice signals into digital data packets for transmission over the Internet or cloud; and broadband Internet services, as well as develops end user portals for account and license management, and billing and customer support. This segment is also involved in the sale and lease of cloud telecommunications equipment. In addition, it offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over high-speed internet connection through various devices and user interfaces, such as desktop phones and/or mobile, and desktop applications under the Crexendo brand name. The Software Solutions segment provides a suite of unified communications, collaboration, video conferencing, and contact center solutions. This segment also offers SNAPsolution, an IP-based platform; SNAPaccel, a software-as-a-service based software; subscription maintenance and support services; and professional services, including consulting, technical support, resident engineer, design, and installation services. The company was formerly known as iMergent, Inc. and changed its name to Crexendo, Inc. in May 2011. Crexendo, Inc. was incorporated in 1995 and is based in Tempe, Arizona.

Kaltura stock logo

Kaltura NASDAQ:KLTR

$1.36 +0.05 (+3.41%)
As of 02:16 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Kaltura, Inc. provides various software-as-a-service (SaaS) products and solutions and a platform-as-a-service (PaaS) in the United States, Europe, the Middle East, Africa, and internationally. The company operates through two segments, Enterprise, Education, and Technology (EE&T); and Media and Telecom (M&T). It offers video products, such as virtual and hybrid events, webinars, video portals, online learning, and content portals for training, marketing, virtual and hybrid events, communication, collaboration, sales, and customer care; and education solutions, such as learning management system video and lecture capture solutions. The company also provides online video experiences, including for over-the-top (OTT) television, cloud TV, web video publishing, video-based teaching, learning, training, video-based marketing, and video-based collaboration. In addition, it offers application programming interfaces (APIs), software development kits, and experience components, including live, real-time and on-demand video, ingestion, transcoding, enrichment, management, distribution, engagement, monetization, and deep viewer analytics, as well as video player, video editor, video capture tool, and chat and networking widgets. The company serves a range of industries, including financial services, high technology, healthcare and pharmaceuticals, education, public sector, media, telecommunications, information technology (IT) and professional services, retail, and manufacturing. Kaltura, Inc. was incorporated in 2006 and is headquartered in New York, New York.

Marchex stock logo

Marchex NASDAQ:MCHX

$1.30 +0.02 (+1.17%)
As of 02:17 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Marchex, Inc., a conversation intelligence company, provides conversational analytics and related solutions in the United States, Canada, and internationally. Its products include Marketing Edge that identifies which campaigns and channels are driving inbound conversations, evaluates what happens during those conversations, and closes the sales loop by connecting converted sales to marketing driven leads; Sonar Business Text Messaging, an artificial intelligence (AI) empowered intelligent workflow enabled mobile messaging solution that enables operations, sales, and marketing teams to communicate personally with field staff, prospects, and customers; Marchex Platform Services, a robust API-based conversation intelligence product that allows executives, sales, customer engagement, and marketing teams to apply Marchex AI to most any calls, regardless of communication platform, in order to identify actionable insights from conversations with their customers; Spotlight, an AI conversation analytics product for multi-location businesses; and Engage, a solution that provides locations with applications to enhance their overall performance. The company was incorporated in 2003 and is headquartered in Seattle, Washington.

Coeptis Therapeutics stock logo

Coeptis Therapeutics NASDAQ:ZSQR

$5.32 -0.34 (-6.01%)
As of 01:57 PM Eastern

Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company also offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas